Hynion: Settlement announcement

Euronext Markets
Hynion AS announced settlement agreements with Bizcap AB and Eminova Fondkomission AB, paving the way for a successful restructuring.

Summary

Hynion AS announced on January 29, 2026, that it has entered into settlement agreements with Swedish credit investor Bizcap AB and associated co-investors, as well as Eminova Fondkomission AB, regarding outstanding debt. The terms of the settlement agreement with Bizcap are confidential. These agreements are expected to lead to a successful restructuring of the company, and Hynion will provide further details to the market in due course. The company considers this information to be inside information subject to EU Market Abuse Regulation and Norwegian Securities Trading Act requirements.

(Source:Euronext Markets)

WBRZ

$5M lawsuit claims Disney's California theme parks illegally collect facial recognition data

CP24 Toronto

Judge approves class action lawsuit launched by Quebec TV personality

The Bradenton Times

Maryland reaches $4.1M settlement with homebuilder in sediment pollution case

Tekedia

Tether Invests on LemFi to Accelerate Stablecoin Settlement Flow in Africa and Asia

Headtopics

President Trump, Family, and Businesses Shielded from Pending Tax Audits as Part of DOJ Settlement

Bitcoin News

Evernorth Highlights XRP’s ‘Actual Story’ Beyond JPMorgan Settlement Attention

Punch

SEC fixes June 1 for T+1 settlement cycle transition

Firstpost

Why is Trump’s new IRS settlement triggering allegations of ‘self-dealing’?

Syracuse Ny Local News

Government to permanently drop tax claims against Trump family as part of lawsuit settlement

USA TODAY

Disney sued over facial recognition at California theme parks

New York Post

Disneyland targeted in class-action lawsuit claiming new program is violating guests' privacy

Bangor Daily News

Journalists sue tech giants over 'stolen' voices for AI training

The Mercury News

Disneyland hit with $5 million lawsuit over use of facial recognition technology

Devdiscourse

UPDATE 4-Takeda engaged in antitrust scheme to delay generic constipation drug, US jury finds

The Japan Times

Takeda engaged in antitrust scheme to delay generic constipation drug: U.S. jury